Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-interferon and Ribavirin in Hemophiliacs With and Without HIV Coinfection
NCT00055341Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Mar 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2002; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00055341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00055341.